Search research articles
Contact Us
Filters
Showing results (201-210 of 339) with videos related to
Page
of 34
Sort By:
Cytokine
|
August 12, 2004
Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study
Magdalene M George, S David Li, Ayse L Mindikoglu, et al.
Plos One
|
February 26, 2016
Myelin Water Fraction Is Transiently Reduced after a Single Mild Traumatic Brain Injury--A Prospective Cohort Study in Collegiate Hockey Players
Alexander D Wright, Michael Jarrett, Irene Vavasour, et al.
BMC Anesthesiology
|
April 27, 2022
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Chunxia Shi, Zugui Zhang, Jordan Goldhammer, et al.
Journal of the American Chemical Society
|
December 11, 2020
Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation
Yixiang Jiang, Guochao Chen, Xiao-Meng Li, et al.
Clinical Transplantation
|
April 13, 2021
Atelectasis in primary graft dysfunction survivors after lung transplantation
David Li, Jonathan Abele, Justin Weinkauf, et al.
ACS Chemical Biology
|
September 20, 2018
Metabolic Labeling of Pseudaminic Acid-Containing Glycans on Bacterial Surfaces
Gloria Andolina, Ruohan Wei, Han Liu, et al.
Cancer Research
|
June 4, 2008
Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates p53-Bak apoptotic pathway
Jichao Qin, He-Ge Chen, Qin Yan, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 16, 2014
"Better-than-best" evidence? Using family physicians' feedback for 2-way knowledge translation
Pierre Pluye, Roland Grad, Carol Repchinsky, et al.
Therapeutic Advances in Neurological Disorders
|
February 23, 2011
Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study
Bernard Uitdehaag, Cris Constantinescu, Peter Cornelisse, et al.
The Journal of Clinical Psychiatry
|
June 26, 2003
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder
Eric Hollander, Lorrin M Koran, Wayne K Goodman, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 339) with videos related to
Sort By:
Page
of 34
Cytokine
|
August 12, 2004
Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study
Magdalene M George, S David Li, Ayse L Mindikoglu, et al.
Plos One
|
February 26, 2016
Myelin Water Fraction Is Transiently Reduced after a Single Mild Traumatic Brain Injury--A Prospective Cohort Study in Collegiate Hockey Players
Alexander D Wright, Michael Jarrett, Irene Vavasour, et al.
BMC Anesthesiology
|
April 27, 2022
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Chunxia Shi, Zugui Zhang, Jordan Goldhammer, et al.
Journal of the American Chemical Society
|
December 11, 2020
Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation
Yixiang Jiang, Guochao Chen, Xiao-Meng Li, et al.
Clinical Transplantation
|
April 13, 2021
Atelectasis in primary graft dysfunction survivors after lung transplantation
David Li, Jonathan Abele, Justin Weinkauf, et al.
ACS Chemical Biology
|
September 20, 2018
Metabolic Labeling of Pseudaminic Acid-Containing Glycans on Bacterial Surfaces
Gloria Andolina, Ruohan Wei, Han Liu, et al.
Cancer Research
|
June 4, 2008
Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates p53-Bak apoptotic pathway
Jichao Qin, He-Ge Chen, Qin Yan, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 16, 2014
"Better-than-best" evidence? Using family physicians' feedback for 2-way knowledge translation
Pierre Pluye, Roland Grad, Carol Repchinsky, et al.
Therapeutic Advances in Neurological Disorders
|
February 23, 2011
Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study
Bernard Uitdehaag, Cris Constantinescu, Peter Cornelisse, et al.
The Journal of Clinical Psychiatry
|
June 26, 2003
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder
Eric Hollander, Lorrin M Koran, Wayne K Goodman, et al.
Page
of 34